Cargando…
Myasthenia gravis and myopathy after nivolumab treatment for non‐small cell lung carcinoma: A case report
Here, we report a case of myasthenia gravis and myopathy in a patient treated with nivolumab. A 76‐year‐old man who had been treated with four doses of nivolumab because of non‐small cell lung cancer (NSCLC) presented with proximal‐dominant muscle weakness and fluctuating ptosis and diplopia. Serolo...
Autores principales: | Kim, Je‐Seong, Nam, Tai‐Seung, Kim, Jieun, Kho, Bo‐Gun, Park, Cheol‐Kyu, Oh, In‐Jae, Kim, Young‐Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775222/ https://www.ncbi.nlm.nih.gov/pubmed/31436031 http://dx.doi.org/10.1111/1759-7714.13177 |
Ejemplares similares
-
Nivolumab-Induced Myocarditis Concomitant with Myasthenia Gravis
por: Fukasawa, Yoko, et al.
Publicado: (2017) -
Relapsed Myasthenia Gravis after Nivolumab Treatment
por: Mitsune, Ayumi, et al.
Publicado: (2018) -
Myasthenia Gravis Induced by Nivolumab: A Case Report
por: Mehta, Jeet J, et al.
Publicado: (2017) -
The Epidemiology of Myasthenia Gravis in Korea
por: Lee, Hyung Seok, et al.
Publicado: (2016) -
Myasthenia Gravis Aggravated by Steroid-Induced Isolated Mediastinal Tuberculous Lymphadenitis
por: Nam, Tai-Seung, et al.
Publicado: (2010)